newsfilter
← Latest News
Business Wire·

2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress

Following regulatory approval in the earlier line setting this quarter, Abecma generated $54 million U.S. commercial revenue and saw meaningful growth in demand Recent completion of Hemophilia A and gene editing